Home » FDA APPROVES PERRIGO'S TERCONAZOLE
FDA APPROVES PERRIGO'S TERCONAZOLE
Perrigo has reported that the FDA has approved its terconazole vaginal suppositories for the treatment of yeast infections. The 80-mg product is considered equivalent to Terazol 3 Vaginal Suppositories, an anti-fungal medication made by Ortho-McNeil.
Terconazole prevents fungal organisms from producing vital substances required for growth and function. This drug is effective only for infections caused by fungal organisms.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May